AI assistant
ADHERIUM LIMITED — Capital/Financing Update 2019
Apr 1, 2019
64305_rns_2019-04-01_ad4047d2-fde9-4200-8ac9-c8a67cbfacb7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [211 x 51] intentionally omitted <==
Expiry of Unlisted Options
2 April 2019: Adherium Ltd (ASX: ADR, the Company or Adherium) advises that the following unlisted options in the Company have lapsed:
| Company have lapsed: | ||
|---|---|---|
| Number ofUnlisted Options | To AcquireExercise Price | Expiry Date |
| 625,823 | Fully paid ordinary sharesin Adherium (ASX:ADR)$0.075268 | 31 March 2019 |
Rob Turnbull Company Secretary
About Adherium
Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with over 140,000 sold globally. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of connected medical devices for respiratory medications. The devices and accompanying technology address sub-optimal medication use and strive to improve health outcomes in chronic disease. Learn more at www.adherium.com